Literature DB >> 22395691

Public-private partnerships need honest brokering.

Michel Goldman1.   

Abstract

Mesh:

Year:  2012        PMID: 22395691     DOI: 10.1038/nm0312-341

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

1.  Pharma embraces open source models.

Authors:  Stephen Strauss
Journal:  Nat Biotechnol       Date:  2010-07       Impact factor: 54.908

Review 2.  The FDA critical path initiative and its influence on new drug development.

Authors:  Janet Woodcock; Raymond Woosley
Journal:  Annu Rev Med       Date:  2008       Impact factor: 13.739

3.  Open innovation networks between academia and industry: an imperative for breakthrough therapies.

Authors:  Teri Melese; Salima M Lin; Julia L Chang; Neal H Cohen
Journal:  Nat Med       Date:  2009-05       Impact factor: 53.440

4.  A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion.

Authors:  Philippe Ravassard; Yasmine Hazhouz; Séverine Pechberty; Emilie Bricout-Neveu; Mathieu Armanet; Paul Czernichow; Raphael Scharfmann
Journal:  J Clin Invest       Date:  2011-08-25       Impact factor: 14.808

  4 in total
  4 in total

Review 1.  The supply chain of human pancreatic β cell lines.

Authors:  Raphael Scharfmann; Willem Staels; Olivier Albagli
Journal:  J Clin Invest       Date:  2019-09-03       Impact factor: 14.808

Review 2.  Open innovation and external sources of innovation. An opportunity to fuel the R&D pipeline and enhance decision making?

Authors:  Alexander Schuhmacher; Oliver Gassmann; Nigel McCracken; Markus Hinder
Journal:  J Transl Med       Date:  2018-05-08       Impact factor: 5.531

3.  Public-private partnerships as driving forces in the quest for innovative medicines.

Authors:  Michel Goldman; Carolyn Compton; Barbara B Mittleman
Journal:  Clin Transl Med       Date:  2013-01-15

4.  International clinical trials setting for rare cancers: organisational and regulatory constraints-the EORTC perspective.

Authors:  Emad Shash; Anastassia Negrouk; Sandrine Marreaud; Vassilis Golfinopoulos; Denis Lacombe; Francoise Meunier
Journal:  Ecancermedicalscience       Date:  2013-05-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.